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Lp(a) and LDL induce apoptosis in human endothelial cells with chronic inflammatory diseases [2]. Lipoproteins
and in rabbit aorta: Role of oxidative stress. such as low-density lipoprotein (LDL) and lipoprotein
Background. Atherogenic lipoproteins cause injury to the (a) [Lp(a)], particularly in their oxidized form, are con-vascular wall in the early phase of atherogenesis. We assessed
sidered to play a key role in the development of prema-the effects of native (nLDL) and oxidized (oxLDL) low-density
ture atherosclerosis [3–5] and contribute to the proin-lipoprotein (LDL) and lipoprotein (a) [Lp(a)] on O22 forma-
tion and cell death in cultured human umbilical vein endothelial flammatory state within the vascular wall [6]. However,
cells (HUVECs) and rabbit aorta (RA). the precise mechanisms of how atherogenic lipoproteins
Methods and Results. O22 formation of HUVECs and RA affect vascular biology are still a matter of debate [5].segments was not influenced by nLDL, but was dose depen-
Experiments in animals have revealed that arteries ob-dently increased by oxLDL and was moderately increased by
nLp(a). oxLp(a) was the most potent stimulus for O22 forma- tained from hypercholesterolemic rabbits produce rela-
tion, increasing it in HUVECs by 356% at 5 mg/ml and in tively high amounts of O22 [7, 8]. Increased formation
RA by 294% at 100 mg/ml. Apoptosis was detected by DNA of O22 could contribute to the inflammatory cascade infragmentation and Annexin assay in HUVECs and by TUNEL
the vessel wall [9], leading to lesion formation. Further-staining in RA. Incubation of HUVECs and RA with oxLDL,
more, it provides an explanation for arterial endothelialbut not nLDL, dose and time dependently induced apoptosis
with only a minimal effect on necrosis. nLp(a) elicited a small dysfunction, a well-known phenomenon observed in hy-
but significant effect on apoptosis, whereas oxLp(a) induced percholesterolemia and atherosclerosis [10–13]. Experi-
apoptosis more potently than oxLDL in HUVECs and RA and
mental data from our laboratory suggest that the stimuluscaused necrotic cell death in HUVECs. Induction of apoptosis
for vascular O22 formation is oxidized LDL (oxLDL)by oxLDL and oxLp(a) in RA was enhanced by the superoxide
dismutase (SOD) inhibitor, diethyl-dithio-carbamate, and was and/or Lp(a) [14], lipoproteins that accumulate in the
blunted by SOD and catalase in HUVECs and RA, suggesting vessel wall in hypercholesterolemia [15, 16] and also in
that O22 formation was involved. The concentration of lysopho- the glomerulus [17]. In the arterial wall, stimulation ofsphatidylcholine, a lipoprotein oxidation product and stimulus
O22 formation may have profound long-term effects onfor O22 formation, was significantly enhanced by factor 5 in
oxLDL and by factor 7 in oxLp(a) compared with native lipo- vessel biology, besides its more acute effect on nitric oxide-
proteins. mediated, endothelium-dependent dilations. The gener-
Conclusion. Atherogenic lipoproteins stimulate O22 forma- ation of oxygen radicals has been demonstrated to betion and induction of apoptosis in HUVECs and RA, and may
involved in mediating apoptotic cell death in numerousthereby influence the pathogenesis of atherosclerosis.
cells [18–21], including endothelial cells [22]. Vascular
regions that are prone to develop atherosclerotic lesions—
those that produce O22—are characterized by increasedAtherosclerosis and glomerulosclerosis have patho-
cell turnover during the early phase of the disease [23],genic pathways in common [1] and share many features
and apoptotic cell death has frequently been found in
human and animal atherosclerotic lesions [24–26]. Thus,Key words: lipoprotein, apoptosis, atherogenesis, superoxide radical,
endothelium, lysophosphatidylcholine. oxidized lipoproteins may affect vascular apoptotic cell
death via stimulation of O22 formation, and the proath-Received for publication July 24, 1998
erogenic potential of lipoproteins may depend on theirand in revised form November 2, 1998
Accepted for publication November 3, 1998 potency to stimulate O22 formation and apoptosis.
In a previous study, we could indeed demonstrate that 1999 by the International Society of Nephrology
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oxLDL induces apoptosis in human umbilical vein endo- varied between 180 and 200 mg/dl before heparin-induced
extracorporeal LDL precipitation treatment and decreasedthelial cells (HUVECs) [27]. In that study, activation
of CPP32, a member of the interleukin-1b–converting by 70% during LDL apheresis. The regenerate fluid was
ultracentrifuged first at a density of 1.065 g/ml and thenenzyme-like protease family and a key molecule in the
cascade leading to apoptotic cell death [28, 29], was iden- at 1.120 g/ml, and was then subjected to density gradient
ultracentrifugation. Finally, Lp(a) was purified using seph-tified as mediator of oxLDL-induced apoptosis. Further-
more, we provided indirect evidence for the involvement adex G-25M gel chromatography and lysine-sepharose
4B chromatography, and was dialyzed extensively againstof the formation of reactive oxygen species.
It was the aim of this study to characterize (1) the 150 mm NaCl, 1 mm ethylenediaminetetraacetic acid
(EDTA; pH 7.4). Lipoprotein (a) was analyzed for puritydirect influence of atherogenic lipoproteins [such as na-
tive LDL (nLDL), oxLDL, nLp(a), and oxLp(a)] on O22 by 0.6% agarose gel electrophoresis, as well as by 4%
sodium dodecyl sulfate-polyacrylamide gel electropho-formation of cultured endothelial cells and of isolated
arteries and, (2) to study and compare the effects of resis (SDS-PAGE).
Protein content of lipoproteins was measured using athese lipoproteins on apoptotic cell death in rabbit aorta
(RA) under perfusion conditions and in HUVECs. To commercially available kit (Sigma protein kit), which is
based on a modification of a method initially describedprovide a link between the formation of O22 and the
induction of apoptosis in HUVECs and RA, we investi- by Lowry et al [33]. Lipoprotein concentrations are al-
ways given as mg protein per ml solution.gated the potential protective effects of antioxidants on
lipoprotein-induced apoptosis and the potential stimula-
Oxidation of lipoprotein (a) andtory effect of superoxide dismutase (SOD) inhibition.
low-density lipoproteinFurthermore, we determined and compared the concen-
tration of lysophosphatidylcholine (lyso-PC) in the dif- Lipoprotein (a) and LDL were oxidized as described
recently [32]. Briefly, antioxidant-free LDL or Lp(a) (0.3ferent lipoprotein preparations, a lipoxidation product
that may be responsible for some of the pathophysiologi- mg protein/ml) were incubated with CuSO4 (5 mm) in
phosphate-buffered saline (PBS) for 30 hours at 238C.cal effects of oxLDL and oxLp(a) [30, 31].
The degree of oxidation was quantitated by two different
methods: (a) the increase in relative mobility on agarose
METHODS
gel, indicating an enhanced negative charge of oxidized
Reagents lipoprotein, and (b) the formation of thiobarbituric acid-
reactive substances [34]. Homogeneity of lipoproteinsSuperoxide dismutase, catalase, 4,5 dihydroxy-1,3-
benzene disulfonic acid salt (TIRON), diethyl-dithio-carba- was tested by agarose gel electrophoresis (REP-HDL-
plus cholesterol electrophoresis; Helena Diagnostika,mate (DDC), CuSO4, lucigenin, bovine serum albumin
(BSA), endothelial basal medium, trypsin, hydrocortisone, Hartheim, Germany). The relative mobility of oxLDL
and oxLp(a) on agarose gel electrophoresis as an indexgentamicin, amphotericin B, primulin, phosphatidylcho-
line, synthetically produced lyso-PC, and paraform- for lipoprotein oxidation was 1.7 to 2.1 compared with
nLDL and nLp(a), respectively. Levels of thiobarbituricaldehyde were obtained from Sigma (Munich, Ger-
many). Epidermal growth factor (EGF) and 10% fetal acid-reactive substances, determined in samples con-
taining 0.3 mg lipoprotein per ml, were 0.2 6 0.01 mmcalf serum (FCS) were from GIBCO (Gaithersburg, MD,
USA). N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic in nLDL, 0.2 6 0.01 mm in nLp(a), 3.9 6 0.7 mm in
oxLDL, and 4.6 6 0.9 mm in oxLp(a). Lp(a) was storedacid (HEPES) buffer, Annexin-V-FLUOS, and propid-
ium iodid were obtained from Boehringer (Mannheim, at 10 to 128C in the dark because of the tendency of low
molecular weight Lp(a) to form a gel by self-associationGermany).
at lower temperatures. Lipoproteins were freshly pre-
Isolation of low-density lipoprotein and lipoprotein (a) pared every two weeks. During this period, apo(a) iso-
forms and apolipoprotein B were intact and not degraded.Human LDL and Lp(a) were isolated as described
recently [32]. Low density lipoprotein was prepared from
Culture of human umbilical vein endothelial cells andpooled, fresh human plasma and, in single experiments,
incubation with lipoproteinsfrom the patient who served as a source for Lp(a). If
not indicated otherwise, all experiments were performed Human umbilical vein endothelial cells were pur-
chased from Cell Systems/Clonetics and were culturedwith LDLs from pooled plasma. Lp(a) was prepared
from an Lp(a)-enriched regeneration fluid, obtained in endothelial basal medium supplemented with hydro-
cortisone (1 mg/ml), bovine brain extract (12 mg/ml),from a single patient treated regularly with an LDL-
apheresis system based on heparin-induced extracorpo- gentamicin (50 mg/ml), amphotericin B (50 ng/ml), EGF
(10 ng/ml), and 10% FCS until the third passage. Thereal LDL precipitation (Braun Melsungen, Melsungen,
Germany). The serum Lp(a) concentration of the patient cells were incubated with native or oxLDL or Lp(a) or
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their respective buffers as control or with lyso-PC in the was kept constant at 30 ml/hr. Preliminary experiments
revealed that in the absence of EDTA, nLDL underwentabsence of lipoprotein, and were taken for detection of
oxidative modification during the 12- and 24-hour incu-apoptosis or O22 formation. In some experiments, the
bation periods. Therefore, all experiments were carriedcells were additionally incubated with 10 mm DDC, an
out in the presence of 100 mm EDTA to prevent oxida-inhibitor of the endogenous SOD.
tion of the native lipoproteins. In some of the experi-
Detection of apoptosis and necrosis in human ments, the arteries were additionally incubated with
umbilical vein endothelial cells DDC (10 mm), an inhibitor of the endogenous vascular
SOD, and/or with the antioxidants SOD (0.1 mm) andIn HUVECs, apoptosis was detected and distinguished
catalase (100 U/ml), enzymes preventing the accumula-from necrosis after 18 hours of incubation with the lipo-
tion of O22 and of H2O2. Aortic segments incubated withproteins by (a) staining with Annexin-V-FLUOS and (b)
the respective buffers of the substances or lipoproteinsdetection of DNA fragmentation. For the Annexin assay,
served as time-matched controls. In order to test forcells (1 3 106) were washed with PBS, removed from the
viability of the aortic segments, outer vascular diametersculture dish with Trypsin/EDTS, centrifuged at 200 3 g,
were recorded by a photoelectric device [35], and vaso-and resuspended in 150 ml 10 mm HEPES/NaOH, pH 7.4,
constrictions were induced at the start as well as at the
140 mm NaCl, 5 mm CaCl2 containing 1 mg/ml propidium end of the incubation periods by potassium-enriched
iodide, and 20 ml/ml Annexin-V-FLUOS. After a 15- Tyrode’s solution (K1, 50 mm). Contractile responses
minute incubation period at room temperature, a 500 ml induced by potassium depolarization of aortic segments
cell culture medium was added, and the cells were ana- were preserved even after long-term incubation (data
lyzed by flow cytometry (FACScan; Becton Dickinson, not shown). Following incubation, the segments were
Mountain View, CA, USA). DNA fragmentation analy- taken off the organ bath, imbedded in tissue freezing
sis was carried out as described recently [22] with a cell medium (Jung, Leica Instr., Nusslach, Germany), and
death detection assay (Boehringer-Mannheim Biochem- frozen in liquid nitrogen. Kryostat sections (thickness 5
icals). Briefly, cells were scraped off the plates and centri- mm) were prepared by a microtom (Jung-CM 3000, Leica
fuged at 700 3 g for 10 minutes, washed with PBS, and Instr., Nusslach, Germany) and stained as described later
resuspended in incubation buffer. After a dilution of in this article.
1:10 in incubation buffer, the histone-associated DNA
TUNEL and 4,6-diamidino-2-phenylindole (DAPI)fragments were linked to the antihistone antibody from
The induction of apoptosis in lipoprotein treated arter-mouse and the DNA part of the nucleosome to the anti-
ies was quantitated by terminal deoxy transferase uridineDNA-peroxidase. The amount of peroxidase retained
triphosphate nick end labeling (TUNEL) staining. Kry-in the immunocomplex was determined photometrically
ostat sections of RA (5 mm) were fixed in 4% paraformal-with 2,29-azino-di-[3-ethylbenzthiazoline sulfonate] as a
dehyde in standard saline citrate, dehydrated, and storedsubstrate.
at 2808C. Fragmented DNA was detected using the In
Vessel preparation and incubation with lipoproteins Situ Cell Death Detection Kit (Boehringer Mannheim
Biochemicals). No endogenous peroxidase activity wasSegments of the aorta (0.8 cm in length) were obtained
present. Sections were permeabilized by microwave treat-from rabbits of either sex (New Zealand rabbits, four to
ment (5 min at 360 W in 10 mm sodium citrate), incubatedfive months old, 2.5 to 3.5 kg). All procedures were
with terminal deoxynucleotidyl transferase for 30 min-carried out in accordance with the guidelines of the Ger-
utes at 378C, and counterstained with 1 mg/ml DAPI inman Ministry of Agriculture for the use and care of
PBS. Stained sections were analyzed under a fluores-laboratory animals. The influence of the lipoproteins on
cence microscope. The rate of apoptosis is expressedthe induction of apoptosis in intact vessels was investi-
as the percentage of TUNEL-positive cells to DAPI-gated under continuous perfusion conditions. For this
positive cells.
purpose, the intact segments were cannulated at both
ends with steel cannulas and placed in an organ bath Detection of O22 formation by lucigenin
containing oxygenated Tyrode’s solution of the following chemiluminescence and by cytochrome c assay
composition (in mm): Na1 144, K1 4, Ca11 1.6, Mg11 To investigate the O22 formation from vascular cells,
1.0, Cl2 140, HCO32 11.9, H2PO42 0.4, glucose 11; pO2 we used a chemiluminescence assay with lucigenin that
120 mm Hg, 378C, pH 7.4, as described recently [14]. reacts specifically with O22, resulting in the release of
Perfusion routes for bath perfusion and intraluminal per- photons, which can be detected in a photomultiplier
fusion were separate. The transmural pressure was ad- tube. This method is highly sensitive and allows the study
justed hydrostatically to 60 mm Hg. The segments were of time kinetics. In additional control experiments, we
intraluminally perfused with nLDL or oxLDL (300 mg/ used the cytochrome c assay as a detector system for
ml) or nLp(a) or oxLp(a) (30 mg/ml) at a perfusion rate O22 formation in HUVECs (discussed later in this arti-
cle) [36]. The presence of lucigenin (0.25 mm) had noof 2 ml/hr for 6, 12, and 24 hours. The bath perfusion
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influence on the signal intensity in the cytochrome c oxLDL or 30 or 50 mg/ml oxLp(a) or their respective
assay. Detection of chemiluminescence with lucigenin buffers as the control) in the presence of 20 mm cyto-
was carried out as described recently [32] in a scintillation chrome for 24 hours. Reduction of cytochrome c was
counter with a single photomultiplier tube (Lumat LB detected photometrically by recording the extinction of
9501/16; Berthold-Instruments, Wildbad, Germany). To 1 ml of the cell supernatant at 550 nm at the end of the
determine the chemiluminescence elicited by arteries incubation period. To correct for background, extinction
treated with atherogenic lipoproteins, segments of the induced by all substances in the absence of cells was
abdominal aorta were prepared (8 mm in length) and subtracted. Specificity of the assay was tested by coincu-
incubated for 60 minutes at 378C in Krebs-HEPES buffer bation with SOD (0.1 mm) and catalase (100 U/ml), which
containing 100 or 300 mg/ml nLDL or oxLDL or 30 or prevented the increase in the reduction of cytochrome
100 mg/ml nLp(a) or oxLp(a) or their respective buffers c. At the end of the experiments, the protein content of
as control. Incubations were carried out in the presence the cells in each dish was determined (Sigma protein
of 10 mm DDC because preliminary experiments re- kit), and O22 formation was expressed in nm O22 per mg
vealed that the signals obtained in the absence of an protein.
SOD inhibitor were below detection limit. Thereafter,
the segments were transferred into the scintillation vials Lysophosphatidylcholine concentration in low-density
containing 0.25 mm lucigenin in a final volume of 2 ml. lipoprotein and lipoprotein (a)
Counts were obtained at one minute intervals at room The concentration of lyso-PC was determined as de-
temperature. To correct for background, counts obtained scribed recently [37]. Lipids were extracted from the
from vials containing all components with the exception lipoproteins (nLDL, oxLDL, nLp(a), and oxLp(a), all
of the aortic rings were subtracted from these signals. lipoproteins prepared from plasma of the same patient)
To detect O22 formation of HUVECs treated with by the method of Folch, Lees and Sloane-Stanley [38]:
lipoproteins, approximately 1 3 105 cells were incubated To 100 ml of the lipoprotein solution (protein concentra-
in a culture dish. The cells were kept at 378C in a cell tion of approximately 1 mg/ml) were added 133 ml metha-
incubator (Heraeus-Instruments, Stuttgart, Germany) nol, and then 267 ml chloroform. The mixtures were
with 5% CO2 in a humidified atmosphere. Than the cells shaken vigorously and then centrifuged to separate the
were stimulated with either nLDL or oxLDL or nLp(a) phases. The upper phases were carefully withdrawn and
or oxLp(a) (1 to 50 mg/ml) or their respective buffers as washed with 300 ml of synthetic lower phase. The com-
the control for 60 minutes. In some experiments, the cells bined lower phases were taken to dryness under a stream
were additionally incubated with 10 mm DDC during the of N2 and then redissolved in 100 ml chloroform/metha-final 10 minutes of the stimulation period. Immediately
nol (2:1 vol/vol). Aliquots of 20 ml were applied to anafter the stimulation period, the cells were harvested
HPTLC plate (Merck Kieselgel 60, 20 3 10 cm) in 1 cmby incubation with a mixture of collagenase (1 mg/ml),
wide streaks. The plate was developed with chloroform/soybean trypsin inhibitor (1 mg/ml), and BSA (2 mg/ml)
methanol/water (70/30/5 by vol). After drying thoroughly,for 30 minutes at 378C. Next, the cell suspension was
the plates were sprayed with a solution of primulin (10washed by mild centrifugation (200 g) in HEPES buffer
mg/ml in acetone/water, 4/1 by vol). The substances wereof the following composition (in mm): CaCl 3 2 H2O quantitated by fluorescence scanning (CAMAG TLC1.8, KCl 2.6, MgCl2 3 6 H2O 0.5, NaCl 137, HEPES 9.1,
scanner, Berlin, Germany; fluorescence mode, excitationglucose 2.8, NaH2PO4 0.35, pH 7.3, and BSA 1 mg/ml.
366 nm, detection .400 nm) and comparison of the areasFinally, the cells were transferred into the scintillation
under each peak with those of standards with known con-vials containing 0.25 mm lucigenin in a final volume of
centrations were run in parallel on the same plate. Lyso-1 ml HEPES buffer. Counts were obtained at one-minute
PC concentrations are expressed as nm/mg lipoprotein.intervals at room temperature. To correct for the back-
ground, counts obtained from vials containing all compo- Statistics
nents with the exception of the HUVECs were sub-
Data are presented as means 6 sem of N experiments.tracted from these signals. At the end of the experiments,
Statistical difference of data in Figures 1 and 2 was deter-the protein content of the cells in each vial (Sigma pro-
mined by comparing the area under the curve with atein kit), and the dry weight of each aortic segment was
computed software program (SigmaPlot; Jandel Scien-determined. The time course of the chemiluminescence
tific, Corte Madera, CA, USA). The statistical differencesignal of HUVECs is always shown as scintillation counts
of the dose-effect curves in the plots in Figure 3 wasper second and per mg protein, and of aortic segments
determined by the use of two-way analysis of variance.as scintillation counts per second and per mg tissue.
For multiple comparison of data, Bonferroni’s correctionTo detect O22 formation of HUVECs using the cyto-
was applied. Statistical difference of data in Figures 4–7chrome c assay according to the method as described by
was determined by analysis of variance. Differences wereVan Gelder and Slater [36], 1 3 105 cells were incubated
with the atherogenic lipoproteins (50 or 100 mg/ml considered significant at an error probability of P , 0.05.
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Fig. 1. Lipoproteins stimulate O22 formation in cultured endothelial
cells. Time course of the O22 formation in terms of chemiluminescence
of lucigenin (counts per second/mg protein) in untreated cultured humal
umbilical vein endothelial cells (HUVECs; control) and in HUVECs
treated with 5 and 10 mg/ml oxLDL (oxidized low density lipoproteins;
A), with 2.5 and 5 mg/ml nLp(a) [native lipoprotein (a); B], or with 1,
2.5, and 5 mg/ml oxLp(a) [oxidized lipoprotein (a); C] is shown. Incuba-
tions were carried out in the presence of diethyl-dithio-carbamate
(DDC). The lipoproteins dose dependently and significantly stimulated
O22 formation of the endothelial cells. Data are means 6 se of 8 to 10
independent experiments. P , 0.05 for oxLDL, nLp(a), or oxLp(a) vs.
control.
blunted by the O22 scavenger TIRON (10 mm, notRESULTS
shown). Stimulation with nLDL (5 to 30 mg/ml) did notO22 formation in human umbilical vein endothelial
change O22 formation (data not shown). oxLDL (5 tocells and in rabbit aorta
10 mg/ml; Fig. 1A), however, enhanced the signal up to
Impact of native and oxidized LDL and Lp(a) on O22 threefold. nLp(a) (2.5 to 5 mg/ml; Fig. 1B) had only aformation in HUVECs. The chemiluminescence signal
minor effect, whereas oxLp(a) significantly increasedobtained from HUVECs under basal conditions and
O22 formation at concentrations above 1 mg/ml, up toafter treatment (60 minutes of incubation) with athero-
fourfold at a concentration of 5 mg/ml (Fig. 1C). Highergenic lipoproteins in the presence of the SOD-inhibitor
concentrations of oxLDL, nLp(a), and oxLp(a) did notDDC is shown in Figure 1. Under basal, unstimulated
further increase the chemiluminescence signal in theconditions, HUVECs produced a stable chemilumines-
cence signal (control; Fig. 1) that could be completely presence of DDC (data not shown). In the absence of
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Fig. 2. Lipoproteins stimulate O22 formation in rabbit aorta. Time course of the O22 formation in terms of chemiluminescence of lucigenin (counts
per second/mg tissue) in untreated, isolated, intact segments of rabbit aorta (control) and in aortic segments treated with 100 and 300 mg/ml nLDL
(A), with 100 and 300 mg/ml oxLDL (B), with 30 and 100 mg/ml nLp(a) (C), or with 30 and 100 mg/ml oxLp(a) (D) is shown. nLp(a), oxLDL,
and oxLp(a) significantly stimulated O22 formation of the aortic segments. Abbreviations are in the legend to Figure 1. Data are means 6 se of
10 to 12 independent experiments. P , 0.05 for oxLDL, nLp(a), or oxLp(a) vs. control.
DDC, a similar pattern of stimulation was observed; and 100 mg/ml oxLDL, respectively; and 29 6 1 and
35 6 1 nm O22/mg protein in cells treated with 30 andhowever, the concentrations of the lipoproteins required
for an equivalent O22 formation were fivefold to sev- 50 mg/ml oxLp(a), respectively. Data were obtained from
three experiments performed in the absence of DDC.enfold higher (data not shown). Detection of O22 forma-
tion of lipoprotein-incubated HUVECs using the cyto-
Impact of native and oxidized low-density lipoproteinchrome c assay yielded qualitatively similar results as
and Lp(a) on O22 formation in rabbit aortathose obtained with the chemiluminescence method. After
a 24-hour incubation period, O22 formation accounted Figure 2 shows the effect of the atherogenic lipopro-
teins (60-min incubation) on O22 formation in intactfor: 12 6 1 nm O22/mg protein in control cells; 17 6 3
and 26 6 1 nm O22/mg protein in cells treated with 50 segments of RA. Like in HUVECs, there was a basal
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Fig. 3. Lipoproteins induce necrotic and apoptotic cell death in cultured endothelial cells. Dose-effect plot of oxLDL-, nLp(a)-, and oxLp(a)-
induced apoptosis versus necrosis in cultured HUVECs, determined by Annexin assay, is shown. oxLDL dose dependently induced apoptotic cell
death, with only a minimal effect on necrosis (A). nLp(a) had no effect on necrosis, with a weak stimulation of apoptosis (B). oxLp(a) stimulated
apoptotic cell death, with a moderate effect on necrosis (B). Data are means 6 se of three independent experiments. P , 0.05 oxLp(a) vs. nLp(a)
as determined by two-way analysis of variance.
Fig. 4. DNA fragmentation in cultured endothelial cells induced by oxidized lipoproteins. oxLDL- and oxLp(a)-induced apoptosis in HUVECs,
determined by DNA fragmentation, and its inhibition by O22-metabolizing enzymes superoxide dismutase (SOD) and catalase are shown. (A)
Inhibitory effects of SOD (0.1 mm) and catalase (100 U/ml) on oxLDL-induced (10 mg/ml, 18 hr) apoptosis. (B) Inhibitory effects of SOD (0.1
mm) and catalase (100 U/ml) on oxLp(a)-induced (10 mg/ml, 18 hr) apoptosis. Data are means 6 se of five independent experiments. *P , 0.05
oxLDL respectively oxLp(a) vs. control. #P , 0.05 oxLDL respectively oxLp(a) vs. lipoprotein 1 antioxidant.
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Fig. 5. Apoptosis induced by oxidized lipoproteins in intact rabbit aorta. The time course of the occurrence of apoptosis in isolated intact segments
of rabbit aorta, intraluminally perfused with oxLDL (300 mg/ml, A) and oxLp(a) (30 mg/ml, B) for 6, 12, or 24 hours, the enhancement of apoptosis
by the SOD-inhibitor diethyl-dithio-carbamate (DDC, 10 mm), and the inhibition of apoptosis by the O22-metabolizing enzymes SOD (0.1 mm)
and catalase (100 U/ml) is shown here. Apoptosis was determined by TUNEL staining, and the rate of apoptosis is expressed as the percentage
of TUNEL-positive cells. oxLDL- and oxLp(a)-induced apoptosis was significantly enhanced by the presence of DDC. SOD and catalase partly
prevented oxLDL- and oxLp(a)-induced apoptosis. Data are means 6 se of four experiments. *P , 0.05 oxLDL vs. oxLDL 1 DDC, respectively,
oxLp(a) vs. oxLp(a) 1 DDC. #P , 0.05 oxLDL 1 DDC vs. oxLDL 1 DDC 1 SOD/catalase, respectively, oxLp(a) 1 DDC vs. oxLp(a) 1 DDC
1 SOD/catalase.
chemiluminescence signal detectable in aortic segments contrast, incubation of HUVECs with oxLDL (10 to
200 mg/ml) resulted in a dose-dependent induction ofwithout stimulation (control; Fig. 2) that could be com-
pletely blunted with TIRON (not shown). nLDL was apoptotic cell death in the absence of DDC. Treatment
with 200 mg/ml resulted in 75% apoptotic cells, sixfoldwithout effect, whereas 300 mg/ml oxLDL stimulated
O22 formation by a factor of 1.5 (Fig. 2 A, B). In further more than in control cells, and a minor increase of ne-
crotic cell death (Fig. 3A). In the presence of DDC (10accordance with the results obtained in HUVECs,
nLp(a) (30 and 100 mg/ml; Fig. 2C) had a minor impact mm), the potency of oxLDL was increased by a factor
of 2 to 3 (data not shown). nLp(a) did not induce necroticon O22 formation, whereas oxLp(a) was the most potent
stimulus of O22 formation. At a concentration of 100 mg/ cell death, but stimulated apoptotic cell death up to
threefold (Fig. 3B). oxLp(a) had a stronger impact. Aml, O22 formation was enhanced up to twofold (Fig. 2D).
Thus, in agreement with a recent study on renal cells dose of 200 mg/ml oxLp(a) caused an eightfold increase
in both apoptotic (48%) and necrotic cells (17%; Fig.from our laboratory [32], oxLp(a) was the lipoprotein
with the strongest effect on O22 formation. 3B). In additional control experiments, we investigated
the effect of 10 to 200 mg/ml oxLDL obtained from the
Apoptosis in human umbilical vein endothelial cells patient who served as Lp(a) donor to compare directly
and in rabbit aorta LDL and Lp(a) from the same individual. However,
even in this intraindividual comparison, oxLp(a) wasWe next determined and compared the effects of the
atherogenic lipoproteins on cell death in HUVECs and significantly more potent than oxLDL (N 5 3, data not
shown).aortic segments of RA. Apoptosis in HUVECs was de-
tected by the Annexin assay and DNA fragmentation, Prevention of apoptosis in HUVEC by SOD and cata-
lase. To investigate whether oxidative stress might beand was distinguished from necrosis by propidium iodid
staining. The induction of apoptosis in lipoprotein- involved in the induction of apoptosis in HUVECs, we
incubated the cells with the atherogenic lipoproteins intreated arteries is given as the percentage of TUNEL-
positive cells. the presence of the O22-catabolizing enzymes SOD or
catalase. Superoxide dismutase and catalase were givenOxidized LDL and Lp(a) induce apoptotic cell death
in HUVEC. In the absence of the SOD-inhibitor DDC, in combination because O22 formation in the presence
of an excess of SOD over catalase might result in theincubation of HUVECs with nLDL (10 to 200 mg/ml)
had no influence on cell survival (data not shown). In generation of highly toxic hydroxyl radicals [39]. DNA
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Fig. 7. Lysophosphatidylcholine (LPC) induces apoptotic cell death in
cultured endothelial cells. The dose-effect plot of LPC-induced apopto-
sis (d) versus necrosis (s) in cultured HUVECs, determined by
Annexin-assay is shown. LPC dose dependently induced apoptotic cell
death without effect on necrosis. Data are means 6 se of three indepen-
Fig. 6. High lysophosphatidylcholine concentration in oxidized lipo- dent experiments (se was smaller than symbol size).
proteins. Lysophosphatidylcholine concentration (lyso-PC, nm/mg lipo-
protein) in nLDL, oxLDL, nLp(a), and oxLp(a) is shown. Lipoprotein
preparations were from plasma of the same individual and were oxidized
according to a standardized protocol. Data are means 6 se of three cell death by oxLDL and oxLp(a) seemed to be mediatedindependent lipoprotein preparations. *P , 0.05 oxLDL, respectively,
by oxidative stress. Further evidence for the involvementoxLp(a) vs. nLDL resp. nLp(a).
of oxygen radicals was the effect of coincubation with
antioxidants, as SOD (0.1 mm) and catalase (100 U/ml)
significantly reduced apoptotic cell death. In agreement
fragmentation as index for apoptotic cell death was not with the results obtained in HUVECs, oxLp(a) had the
altered by SOD or catalase in control cells (Fig. 4). How- strongest effect on apoptosis.
ever, exposure to SOD (0.1 mm) or catalase (100 U/ml)
Formation of lysophosphatidylcholine in oxidativelyinhibited the induction of apoptosis induced by oxLDL
modified lipoproteins and induction of apoptosis(10 mg/ml; Fig. 4A) or by oxLp(a) (10 mg/ml; Fig. 4B).
by lysophosphatidylcholineWhen given in combination, SOD and catalase decreased
the apoptosis rate below control levels. Thus, stimulation Formation of lyso-PC through the activity of phospho-
of apoptotic cell death by oxLDL and oxLp(a) seems to lipase A2 on phosphatidylcholine is a well-known reac-
be mediated by oxidative stress. tion occurring during oxidative LDL modification [40]
Oxidized LDL and Lp(a) induce apoptotic cell death and is likely to also take place during oxidation of Lp(a).
in rabbit aorta. Native LDL (up to 300 mg/ml) and nLp(a) Lyso-PC may be responsible for part of the effects of
(up to 100 mg/ml) were without significant effect on oxidized lipoproteins on endothelial function [31] and
apoptosis of intact, isolated, continuously perfused seg- has been shown to induce O22 formation in RA [30].
ments of RA after 6, 12, or 24 hours of incubation, com- We therefore determined the lyso-PC content in nLDL,
pared with untreated control arteries (data not shown). oxLDL, nLp(a), and oxLp(a). As expected, nLDL and
In contrast, perfusion with oxLDL or oxLp(a) resulted nLp(a) contained only low amounts of lyso-PC (Fig. 6).
in a significant induction of apoptotic cell death, as de- However, during oxidative modification of the lipopro-
tected by TUNEL staining of fragmented DNA. Treat- teins, significantly higher concentrations of lyso-PC were
ment with 300 mg/ml oxLDL or with 30 mg/ml oxLp(a) detected (Fig. 6). The lyso-PC concentration was fivefold
caused up to a fourfold induction in the absence of DDC higher in oxLDL compared with nLDL and sevenfold
(Fig. 5) compared with untreated controls. Apoptotic higher in oxLp(a) compared with nLp(a). Therefore, we
cell death was detected in endothelial cells and in all directly studied the effect of lyso-PC on apoptosis. When
layers of smooth muscle cells. Induction of apoptosis HUVECs were incubated with synthetically produced
by oxidized lipoproteins was time dependent and was lyso-PC in the absence of lipoproteins, we observed a
significantly enhanced when the aortic segments were dose-dependent increase in the rate of apoptosis without
stimulated in the presence of DDC, an inhibitor of the any effect on necrosis (detected with the Annexin assay;
endogenous vascular SOD. DDC alone, in the absence Fig. 7). Thus, lyso-PC in oxidized lipoproteins may indeed
of lipoproteins, had no effect on apoptosis of control be a major factor that is responsible for the induction
of apoptosis.arteries. Thus, like in HUVECs, stimulation of apoptotic
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DISCUSSION undergo redox cycling in some enzymatic in vitro systems
[52]. In a more recent publication, however, a linear corre-In this study, we investigated the impact of native
lation between lucigenin-derived chemiluminescence andand oxidatively modified LDL and Lp(a) on the genera-
cytochrome c reduction in enzymatic and cellular O22-tion of oxidative stress and on apoptotic cell death in
generating systems has been shown, thus providing evi-HUVECs and in intact segments of RA. The oxidized
dence that lucigenin-derived chemiluminescence is stilllipoproteins strongly enhanced O22 formation and apop-
a valid probe for the detection of O22 formation [53].totic cell death in HUVECs and aortic segments, with
In view of this ongoing discussion, additional controloxLp(a) being the most potent stimulus for oxidative
experiments were performed using the cytochrome cstress and apoptosis. Stimulation of apoptosis by lipopro-
assay. With the lucigenin method, we could directly de-teins was blunted by antioxidants and was increased by
tect O22 formation from cultured endothelial cells andan SOD inhibitor, emphasizing the key role of stimulated
from intact arteries after stimulation with lipoproteins.O22 formation.
Our experiments yielded essentially identical results withIt is increasingly recognized that apoptotic cell death
cultured HUVECs as with aortic segments. Oxidativeplays an important role in many cardiovascular disorders
modification of lipoproteins greatly enhances their po-[41]. Apoptosis has been identified in human thoracic
tency to stimulate O22 formation, and under our particu-aorta and coronary arteries [24, 26], and importantly,
lar experimental conditions, oxLp(a) is more potent thanapoptosis was common in the lesions and virtually absent
oxLDL. Detection of O22 formation of lipoprotein-incu-in nonatherosclerotic regions [24]. Thus, apoptosis was
bated HUVECs using the cytochrome c assay producedfound in those vascular regions that typically contained
results similar to those obtained with the chemilumines-large amounts of oxidatively modified lipoproteins,
cence method, thus validating our data. The mechanismoxLDL, and oxLp(a) [15, 16, 42]. Experimental data sug-
of the stimulation of O22 formation has still to be eluci-gest that oxLDL and oxLp(a) contribute to the inflam-
dated. The observation that oxidation was a major factormatory state of atherosclerotic lesions [43] and cause
for their stimulatory capacity hints to the lipid peroxida-
injury to endothelial cells [44]. Therefore, it seemed rea-
tion process itself. A potential pathway is the stimulatory
sonable to assume that oxLDL and oxLp(a) could induce influence of lipid peroxidation products on cellular O22-apoptosis in vascular cells. Indeed, stimulation of apop- generating enzymes. During the lipoprotein oxidation,
totic cell death by oxLDL was recently demonstrated in various more or less stable products are formed, includ-
smooth muscle cells, macrophages [45, 46], and human ing lyso-PC, aldehydic lipid peroxidation products, and
endothelial cells [47, 48]. fatty acids produced by phospholipase A2 [54–56]. Lyso-In a previous study using cultured HUVECs, we showed PC, a by-product of cholesterol esterification, has been
that oxLDL causes apoptotic cell death, which is pre- shown to increase O22 formation in vascular smooth
vented by N-acetylcysteine and the combination of vita- muscle cells via the stimulation of protein kinase C [30].
mins C and E [27], providing indirect evidence for the A similar mechanism may take place in endothelial cells.
involvement of the formation of a reactive oxygen spe- The second major issue of this study was the influence
cies. Oxidative stress is an important trigger for apoptosis of atherogenic lipoproteins on apoptosis. We investi-
in general [49] and in vascular cells [18, 22]. Thus, oxida- gated apoptosis not only in cultured cells, but, for the
tive stress caused by oxLDL during the development of first time, also in isolated arteries under perfused condi-
atherosclerosis could have important pathophysiological tions. In line with the data on O22 formation, lipoprotein
consequences. Evidence that the generation of reactive oxidation was also essential for the induction of apop-
oxygen species is enhanced in hypercholesterolemia and/ totic cell death in HUVECs and in aortic segments. In
or atherosclerosis derives from experimental data, as aortic segments, oxLDL caused a significant stimulation
well as from clinical investigations. Arteries isolated from of apoptosis only when the endogenous vascular SOD
hypercholesterolemic rabbits produce large amounts of activity was simultaneously inhibited by DDC. oxLp(a)-
O22 [7, 8]. Lp(a) has been shown to induce formation induced apoptosis by itself after 24 hours of incubation,
of oxygen free radicals in human monocytes [50], and but inhibition of SOD greatly enhanced its effect on
various studies using antioxidants indicate that enhanced apoptotic cell death. This observation underlines the im-
oxidative stress plays a role for vascular biology under portance of oxidative stress in the apoptotic cascade stim-
pathophysiological conditions [9, 51]. ulated by the oxidized lipoproteins. Further evidence is
It was therefore one major issue of this study to exam- provided by the potentiating effect of DDC on apoptosis
ine the influence of the atherogenic lipoproteins on O22 in HUVECs and by the inhibitory effect of SOD and
formation in more detail. For this purpose, we used a catalase on the induction of apoptosis in both aortic seg-
chemiluminescence assay with lucigenin as a specific de- ments and in HUVECs. In a recent study, we identified
tector for O22. The validity of this method has previously activation of CPP32, a member of the interleukin-1b–
converting enzyme-like protease family and a key mole-been questioned because of the ability of lucigenin to
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